Medican Enterprises, Inc.
MDCN
$0.00
$0.000.00%
OTC PK
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -82.00% | 2,958.92% | 45,285.92% | 34,778.26% | 741,243.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -82.00% | 2,958.92% | 45,285.92% | 34,778.26% | 741,243.90% |
| Operating Income | 82.00% | -2,958.92% | -45,285.92% | -34,778.26% | -741,243.90% |
| Income Before Tax | -257.53% | -2,650.28% | -40,663.98% | -33,656.64% | -453,558.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -257.53% | -2,650.28% | -40,663.98% | -33,656.64% | -453,558.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -257.53% | -2,650.28% | -40,663.98% | -33,656.64% | -453,558.21% |
| EBIT | 82.00% | -2,958.92% | -45,285.92% | -34,778.26% | -741,243.90% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 36.88% | -1,412.43% | -23,313.75% | -21,575.26% | -417,188.00% |
| Normalized Basic EPS | 36.88% | -1,394.83% | -23,314.00% | -21,800.00% | -407,406.25% |
| EPS Diluted | 36.88% | -1,412.43% | -23,313.75% | -21,575.26% | -417,188.00% |
| Normalized Diluted EPS | 36.88% | -1,394.83% | -23,314.00% | -21,800.00% | -407,406.25% |
| Average Basic Shares Outstanding | 466.45% | 81.77% | 73.28% | 55.10% | 9.94% |
| Average Diluted Shares Outstanding | 466.45% | 81.77% | 73.28% | 55.10% | 9.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |